REQUEST A DEMO
Total
USD $0.00
Search more companies

C.S.V. Medicines Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: C.S.V. Medicines Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

C.S.V. Medicines Company Limited is based in Thailand, with the head office in Bangkok , Special Governed District of. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on June 01, 2026. There are currently 20 (estimated) people employed by C.S.V. Medicines Company Limited. From the latest financial highlights, C.S.V. Medicines Company Limited reported a net sales revenue increase of 6.38% in 2024. Over the same period, its total assets grew by 19.32%. The net profit margin of C.S.V. Medicines Company Limited decreased by 0.95% in 2024.

Headquarters
37 Ratchawithi Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10700

Contact Details: Purchase the C.S.V. Medicines Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the C.S.V. Medicines Company Limited report to view the information.
Financial Auditors:
Purchase the C.S.V. Medicines Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after C.S.V. Medicines Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
6.38%
Total Operating Revenue
6.35%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
-201.39%
Total Assets
19.32%
Total Equity
-24.5%
Operating Profit Margin
N/A
Net Profit Margin
-0.95%
Return on Equity (ROE)
-24.31%
Debt / Equity
236.62%
Quick Ratio
-0.03%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?